Cooperative Agreement NU58DP007985
- Federal Cooperative Agreement Summary The Maine Department of Health and Human Services received a $425,000 cooperative agreement from the Centers for Disease Control and Prevention (CDC) National Center for Chronic Disease Prevention and Health Promotion under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800). Awarded on August 30, 2025, with a completion date of August 29, 2030, this five-year cooperative agreement funds the Maine Colorectal Cancer...
- Federal Cooperative Agreement Summary The District of Columbia Department of Health received a $681,269 Cooperative Agreement award dated August 30, 2025, under the "Organized Approaches to Increase Colorectal Cancer Screening" program (CFDA 93.800) administered by the National Center for Chronic Disease Prevention and Health Promotion. The five-year program, extending through August 29, 2030, funds the DC Colorectal Cancer Control Program (DC3C), which delivers evidence-based...
- Federal Cooperative Agreement Summary The Massachusetts Department of Public Health (MDPH) received a $1.079 million Cooperative Agreement award from the Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800) on August 30, 2025. The five-year award, scheduled for completion on August 29, 2030, funds MDPH's partnership with the Massachusetts League...
- Summary of Federal Cooperative Agreement Award Comagine Health received a $530,298 cooperative agreement awarded August 30, 2025, by the Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800). In partnership with the Idaho Community Health Center Association, Comagine Health will implement a comprehensive, evidence-based initiative to increase...
- Federal Cooperative Agreement Summary Health Research, Inc.'s Center for Community Health received a $684,000 Cooperative Agreement award dated August 30, 2025, from the National Center for Chronic Disease Prevention and Health Promotion to implement the "Organized Approaches to Increase Colorectal Cancer Screening" program (CFDA 93.800). The five-year project, which extends through August 29, 2030, will increase colorectal cancer (CRC) screening rates across New York State by...
- Federal Cooperative Agreement Summary The Alabama Department of Public Health, Cancer Prevention and Control Division received a $483,280 cooperative agreement awarded August 30, 2025, from the National Center for Chronic Disease Prevention and Health Promotion under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800) to reduce colorectal cancer (CRC) screening disparities in rural Alabama. The program will implement evidence-based interventions to increase CRC...
- Federal Cooperative Agreement Summary The Rhode Island Department of Health (RIDOH) received a $547,200 Cooperative Agreement awarded August 30, 2025, by the Centers for Disease Control and Prevention (CDC) under the "Organized Approaches to Increase Colorectal Cancer Screening" program (CFDA 93.800). The award, which extends through August 29, 2030, funds RIDOH's implementation of evidence-based interventions (EBIs) and patient navigation services to increase colorectal cancer (CRC)...
- Federal Cooperative Agreement Summary The Florida Department of Health (FDOH) received a $684,000 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC), National Center for Chronic Disease Prevention and Health Promotion, under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800). Awarded on August 30, 2025, with performance through August 29, 2030, this five-year award funds the continuation and expansion of Florida's Colorectal Cancer...
- Federal Cooperative Agreement Award Summary The Colorado Department of Public Health and Environment (CDPHE) received a $529,462 Cooperative Agreement award from the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800) effective August 30, 2025, through August 29, 2030. Under this five-year award, CDPHE will implement evidence-based interventions and strategies to increase...
- Federal Cooperative Agreement Summary The Native American Rehabilitation Association of the Northwest, Inc. (NARA NW) received a $502,578 cooperative agreement award from the National Center for Chronic Disease Prevention and Health Promotion (Centers for Disease Control and Prevention) under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800). The award, effective August 30, 2025, through August 29, 2030, funds the "Changing Health Systems Using...
The Oregon Health Authority received a $1,283,254 cooperative agreement from the Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800). Awarded on August 30, 2025, with a completion date of August 29, 2030, this five-year agreement supports Oregon's initiative to strengthen colorectal cancer screening programs across the state. The award funds implementation of evidence-based interventions in partnership with federally qualified health centers (FQHCs), tribal clinics, and other community-based primary care practices to increase CRC screening rates among populations aged 45-75 years, with particular emphasis on underserved and medically underinsured populations. The project targets populations experiencing significant CRC screening disparities, including residents of rural Oregon, uninsured individuals, Oregon Health Plan (Medicaid) beneficiaries, and communities of color. Key deliverables include creation and maintenance of robust CRC screening programs within participating clinics, implementation of evidence-based strategies such as patient and provider reminders, reduction of structural barriers to screening, and assessment and feedback mechanisms to improve screening prevalence. Given that 61 percent of FQHC patients are insured through Oregon Medicaid and current screening rates across Oregon's FQHCs remain below 60 percent, the agreement leverages these clinical networks as critical access points to address documented disparities in colorectal cancer incidence, mortality, and screening rates across Oregon's diverse populations.Federal Cooperative Agreement Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 1/7/26 | ||
| Not listed | $641.6k | 8/25/25 | ||
| Not listed | $641.6k | 8/25/25 |